<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Shares of Moderna Inc. gained 3.1% in trading on Tuesday after the company said an in-vitro study analyzing the sera of people who have received its COVID-19 vaccine had neutralizing antibody titers that protect against infection with several variants, including the worrisome Delta variant. The Delta variant, or B.1.617.2, was first identified in India.
...read full article on Market Watch
